Registro:

Referencias:

• Vapaatalo, H., Mervaala, E., Clinically important factors influencing endothelial function (2001) Med Sci Monit, 7 (5), pp. 1075-1085
• Cines, D.B., Polak, E.S., Buck, C.A., Endotelial cells in physiology and in the pathophysiology of vascular disorders (1998) Blood, 91, pp. 3527-3561
• Cosentino, F., Luscher, T.F., Endothelial dysfunction in diabetes mellitus (1998) J Cardiovasc Pharmacol, 32 (3 SUPPL.), pp. S54-61
• De Vriese, A.S., Verbeuren, T.J., Van De Voorde, J., Lameire, N.H., Vanhoutte, P.M., Endothelial dysfunction in diabetes (2000) Br J Pharmacol, 130 (5), pp. 963-974
• Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Salvetti, A., Endothelial dysfunction in hypertension (2000) J Nephrol, 13 (3), pp. 205-210
• Levin, E.R., Endothelins (1995) N Engl J Med, 333, pp. 356-363
• Haynes, W.G., Webb, D.J., The endothelin family of peptides: Local hormones with diverse roles in health and disease? (1993) Clin Sci, 84, pp. 485-500
• Cowburn, P.J., Cleland, J.G.F., Endothelin antagonists for chronic heart failure: Do they have a role? (2001) Eur Heart J, 22, pp. 1772-1784
• Hopfner, R.L., Gopalakrishnan, V., Endothelin: Emerging role in diabetic vascular complications (1999) Diabetologia, 42, pp. 1383-1394
• Mayer, B., Hemmens, B., Biosynthesis and action of nitric oxide in mammalian cells (1997) Trends Biochem Sci, 22, pp. 477-481
• Andrew, P.J., Mayer, B., Enzymatic function of nitric oxide synthases (1999) Cardiovasc Res, 43, pp. 521-531
• Moncada, S., Higgs, A., The L-arginine-nitric oxide pathway (1993) N Engl J Med, 27, pp. 2002-2011
• Honing, M.L., Morrison, P.J., Banga, J.D., Stroes, E.S., Rabelink, T.J., Nitric oxide availability in diabetes mellitus (1998) Diabetes Metab Rev, 14 (3), pp. 241-249
• Papapetropoulos, A., Rudic, R.D., Sessa, W.C., Molecular control of nitric oxide synthases in the cardiovascular system (1999) Cardiovasc Res, 43, pp. 509-520
• Masuda, H., Azuma, H., Biological and pathophysiological roles of endogenous methylarginines as inhibitors of nitric oxide synthase (2002) Nippon Yakurigaku Zassi, 119, p. 29
• Lip, G., Blann, A., Von Willebrand factor: A marker of endothelial dysfunction in vascular disorders? (1997) Cardiovasc Res, 34, pp. 255-265
• Morise, T., Takeuchi, Y., Kawano, M., Koni, I., Takeda, R., Increased plasma levels of immunoreactive endothelin and von Willebrand factor in NIDDM patients (1995) Diabetes Care, 18, pp. 87-89
• The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) (1997) Arch Intern Med, 157, pp. 2.413-46
• Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge (1972) Clin Chem, 18, pp. 499-502
• Moshage, H., Kok, B., Huizenga, J.R., Jansen, P.L., Nitrite and nitrate determination in plasma: A critical evaluation (1995) Clin Chem, 41, pp. 892-896
• Schiekofer, S., Balletshofer, B., Andrassy, M., Bierhaus, A., Nawroth, P., Endothelial dysfunction in diabetes mellitus (2000) Semin Thromb Hemost, 26, pp. 503-512
• Luscher, T.F., Barton, M., Biology of the endothelium (1997) Clin Cardiol, 20 (11 SUPPL. 2), pp. II-3-10
• Puddu, P., Puddu, G.M., Zaca, F., Muscari, A., Endothelial dysfunction in hypertension (2000) Acta Cardiol, 55 (4), pp. 221-232
• Noll, G., Tschudi, M., Nava, E., Luscher, T.F., Endothelium and high blood pressure (1997) Int J Microcirc Clin Exp, 17 (5), pp. 273-279
• Kahler, J., Ewert, A., Weckmuller, J., Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells (2001) J Cardiovasc Pharmacol, 38 (1), pp. 49-57
• Rossi, G.P., Seccia, T.M., Nussdorfer, G.G., Reciprocal regulation of endothelin-1 and nitric oxide: Relevance in the physiology and pathology of the cardiovascular system (2001) Int Rev Cytol, 209, pp. 241-272
• Brownlee, M., Advanced protein glycosylation in diabetes and aging (1995) Annu Rev Med, 46, pp. 223-234
• Price, D.T., Vita, J.A., Keaney Jr., J.F., Redox control of vascular nitrite oxide biovailability (2000) Antioxid Redox Signal, 2 (4), pp. 919-935
• Zalba, G., Beaumont, J., San Jose, G., Fortuno, A., Fortuno, M.A., Diez, J., Vascular oxidant stress: Molecular mechanisms and pathophysiological implications (2000) J Physiol Biochem, 56 (1), pp. 57-64
• Cosentino, F., Hishikawa, K., Katusic, Z., Luscher, T., High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells (1997) Circulation, 96 (1), pp. 25-28
• Sugita, H., Kaneki, M., Tokunaga, E., Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance (2002) Am J Physiol Endocrinol Metab, 282 (2), pp. E386-94
• Parel, S.T., Kent, K.C., Risk factors and their role in the diseases of the arterial wall (1998) Semin Vasc Surg, 11 (3), pp. 156-168
• Shimokawa, H., Primary endotelial dysfunction: Atheroesclerosis (1999) J Mol Cell Cardiol, 31 (1), pp. 23-37
• Mather, K., Anderson, T.J., Verma, S., Insulin action in the vasculature: Physiology and pathophysiology (2001) J Vasc Res, 38 (5), pp. 415-422
• Baumgartner-Parzer, S.M., Waldhausl, W.K., The endothelium as a metabolic and endocrine organ: Its relation with insulin resistance (2001) Exp Clin Endocrinol Diabetes, 109 (2 SUPPL.), pp. S166-S179
• Blann, A.D., Von Willebrand factor and the endothelium in vascular disease (1993) Br J Biomed Sci, 50, pp. 125-134
• Ouviña, S.M., La Greca, R.D., Zanaro, N.L., Palmer, L., Sassetti, B., Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients (2001) Thromb Res, 102, pp. 107-114
• Freedman, J.E., Loscalzo, J., Endotelial dysfunction and atherothrombotic occlusive disease (1997) Drugs, 54 (3 SUPPL.), pp. 41-49

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------